The Bombay High Court has granted interim relief to Sapat International in a trademark dispute over the century-old SAPAT brand, restrainin...

US President Trump's proposed tariffs on imported generic drugs will not immediately affect Indian drugmakers. Indian companies export sign...

Indian drug shares declined Wednesday following US President Trump's tariff announcement. These proposed tariffs will significantly impact ...

Temasek International sees family businesses opening to investors as a major market shift. Generational transitions create attractive long-...

Singapore's Temasek is exploring investment opportunities within India's Indian Premier League. The league attracts sovereign wealth funds ...

Donald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...

Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...

US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...

The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...

For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...

Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...

The government told Parliament it is closely monitoring developments in its trade relationship with the US and remains engaged with Washing...

Natco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent ...

India's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and...

In a landmark transaction, Warburg Pincus, a prominent US private equity firm, has purchased Integrace Private Limited for ₹1,200 crore. Wi...

South Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement die...

Fund houses experienced robust equity inflows during June. Money managers favored large-cap stocks trading below historical averages. Priva...